Search

Hankyel Park

Examiner (ID: 4694)

Most Active Art Unit
1648
Art Unit(s)
1621, 1648, 1813, 1645, 1643, 1818
Total Applications
631
Issued Applications
474
Pending Applications
102
Abandoned Applications
55

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3756733 [patent_doc_number] => 05843635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Inhibition of APC-mediated apoptosis of activated T lymphocytes' [patent_app_type] => 1 [patent_app_number] => 8/395149 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 7117 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843635.pdf [firstpage_image] =>[orig_patent_app_number] => 395149 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/395149
Inhibition of APC-mediated apoptosis of activated T lymphocytes Feb 26, 1995 Issued
Array ( [id] => 4135365 [patent_doc_number] => 06015665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Method and composition for regulating apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/389812 [patent_app_country] => US [patent_app_date] => 1995-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 9520 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015665.pdf [firstpage_image] =>[orig_patent_app_number] => 389812 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/389812
Method and composition for regulating apoptosis Feb 12, 1995 Issued
Array ( [id] => 3888402 [patent_doc_number] => 05777074 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)' [patent_app_type] => 1 [patent_app_number] => 8/386956 [patent_app_country] => US [patent_app_date] => 1995-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 16682 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777074.pdf [firstpage_image] =>[orig_patent_app_number] => 386956 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/386956
Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) Feb 9, 1995 Issued
Array ( [id] => 3828451 [patent_doc_number] => 05783667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Apoptosis specific Tp30 protein' [patent_app_type] => 1 [patent_app_number] => 8/362221 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 8551 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783667.pdf [firstpage_image] =>[orig_patent_app_number] => 362221 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/362221
Apoptosis specific Tp30 protein Dec 22, 1994 Issued
Array ( [id] => 4256702 [patent_doc_number] => 06258529 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'PCR amplification of rearranged genomic variable regions of immunoglobulin genes' [patent_app_type] => 1 [patent_app_number] => 8/348548 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 13775 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258529.pdf [firstpage_image] =>[orig_patent_app_number] => 348548 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/348548
PCR amplification of rearranged genomic variable regions of immunoglobulin genes Nov 30, 1994 Issued
Array ( [id] => 3831815 [patent_doc_number] => 05814510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Attenuated canine parvovirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/336345 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6118 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814510.pdf [firstpage_image] =>[orig_patent_app_number] => 336345 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/336345
Attenuated canine parvovirus vaccine Nov 7, 1994 Issued
08/335019 NOVEL MATERIALS AND METHODS FOR PRODUCING IMMUNOLOGICAL PROTECTION AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS Nov 6, 1994 Abandoned
Array ( [id] => 1248680 [patent_doc_number] => 06673896 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Derivatives of soluble T-4' [patent_app_type] => B1 [patent_app_number] => 08/328500 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 31815 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673896.pdf [firstpage_image] =>[orig_patent_app_number] => 08328500 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/328500
Derivatives of soluble T-4 Oct 24, 1994 Issued
Array ( [id] => 3808248 [patent_doc_number] => 05831034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Human monoclonal anti-HIV-I-antibodies' [patent_app_type] => 1 [patent_app_number] => 8/293842 [patent_app_country] => US [patent_app_date] => 1994-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 4322 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831034.pdf [firstpage_image] =>[orig_patent_app_number] => 293842 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/293842
Human monoclonal anti-HIV-I-antibodies Aug 21, 1994 Issued
Menu